Considering these findings alongside the pivotal role of NEP in clearing Aβ peptides in the brain, it could potentially serve as a marker for measuring susceptibility to AD and as a target for drug development and therapeutic interventions. The gene discussed is MME; the disease is Alzheimer disease.